Skip to main content
. 2021 Sep 13;9(9):1017. doi: 10.3390/vaccines9091017

Figure 2.

Figure 2

Ratio of median concentrations of anti-SARS-CoV-2 RBD in vaccinated groups versus naturally infected individuals with asymptomatic/mild, moderate/severe and critical infection.